Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis
Clicks: 193
ID: 271536
2000
In experimental visceral leishmaniasis, interleukin (IL)-12 initiates control over Leishmania donovani via Th1 cell activation, interferon (IFN)-gamma secretion, and granuloma formation. Because the leishmanicidal effect of conventional therapy, pentavalent antimony (Sb), also requires T cells and e …
| Reference Key |
hw2000theinterleukin-12
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Murray HW;Montelibano C;Peterson R;Sypek JP;; |
| Journal | The Journal of infectious diseases |
| Year | 2000 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
Mice
animals
pubmed abstract
nih
national institutes of health
national library of medicine
research support
u.s. gov't
P.H.S.
Inbred BALB C
Knockout
leishmaniasis
h w murray
antimony / therapeutic use
visceral / drug therapy*
pmid:11023473
doi:10.1086/315890
c montelibano
j p sypek
interferon-gamma / physiology
interleukin-12 / physiology*
interleukin-4 / physiology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.